Annexon, Inc. ANNX
3.43 USD -0.09 (-2.56%)
As ofNov 19, 2026, 3:37 PM EST
3.40 Day range 3.66
3.36 52-week range 7.18
- YTD
- -31.67%
- 1 year
- -15.52%
Benzinga news
benzinga.com Annexon Q3 EPS $(0.25) Beats $(0.28) Estimate Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.28) by 10.71 percent. This is a 32.43 percent increase over losses of $(0.37) per…
benzinga.com Annexon To Highlight Phase 3 ARCHER II Clinical Trial Program At Virtual Investor Event Company management will highlight the Phase 3 ARCHER II clinical trial design, patient demographics and communication strategy for the anticipated 15-month and 24-month results beginning in Q4 2026.…
benzinga.com Microsoft To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Monday Analysts upgraded Global-E and raised Annexon’s target; targets fell for Truist, Ameriprise, Lyft, A.O. Smith and Hudson Pacific.benzinga.com HC Wainwright & Co. Maintains Buy on Annexon, Raises Price Target to $25 HC Wainwright & Co. analyst Ananda Ghosh maintains Annexon (NASDAQ:ANNX) with a Buy and raises the price target from $14 to $25.
